Merck & Co., Inc. $MRK Stake Reduced by ANTIPODES PARTNERS Ltd
MarketBeat
ANTIPODES PARTNERS Ltd reduced its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 5.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,575,811 shares of the company's stock after selling 95,741 shares during
NYSE:MRK